glp 1 alzheimer's disease GLP-1R agonists protect against by rewiring energy regulation Glucagon like peptide-1 (GLP-1) likes

Peptide receptor radionuclide therapy (PRRT) of medullary and nonmedullary thyroid cancer using radiolabeled somatostatin analogues

While combination therapy with metformin and GLP-1 drugs is evidence-based for many patients, genetic variants in GLP-1 receptor signaling and related pathways may help provide context for how your body utilizes these medications, supporting a more personalized conversation with your healthcare provider

Glucagonlike peptide1 receptor agonists and mental health: a metaanalysis of randomized controlled trials

Quick summary Oral GLP-1 drops deliver a small-molecule or compounded formulation taken by mouth, promising needle-free dosing and home convenience

January 2026: Mitsubishi Tanabe Pharma enhanced development programs in oral antidiabetic therapies to improve long-term disease management outcomes

Daily gut-health hack: Yogurt + oats + banana + date = prebiotics + probiotics + fiber metabolic win